WHO ICTRP trial
The effect of mycophenolate mofetil in controlling the recurrence of idiopathic…
IRCT20130812014333N113 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20130812014333N113 |
|---|---|
| Public title | The effect of mycophenolate mofetil in controlling the recurrence of idiopathic nephrotic syndrome in steroid-dependent children or frequent recurrence |
| Scientific title | The effect of mycophenolate mofetil in controlling the recurrence of idiopathic nephrotic syndrome in steroid-dependent children or frequent recurrence in patients referred to pediatric nephrology clinic, Imam Reza hospital |
| Primary sponsor | Kermanshah University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Nephrotic syndrome. Nephrotic syndrome |
| Interventions | Intervention 1: The intervention group will receive MMF in a dose of 600 mg / m2 every 12 hours. Corticosteroid dose of 60mg / m2 increases for three consecutive days until negative proteinuria. Intervention 2: The control group will not… |
| Registration date | Feb 24, 2019 |
| Target size | 12 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: